Combination of low-dose gemcitabine and recombinant quail vascular endothelial growth factor receptor-2 as a vaccine induces synergistic antitumor activities.
Hou JM, Liu JY, Yang L, Zhao X, Tian L, Ding ZY, Wen YJ, Niu T, Xiao F, Lou YY, Tan GH, Deng HX, Li J, Yang JL, Mao YQ, Kan B, Wu Y, Li Q, Wei YQ.
Hou JM, et al. Among authors: ding zy.
Oncology. 2005;69(1):81-7. doi: 10.1159/000087303. Epub 2005 Aug 2.
Oncology. 2005.
PMID: 16088235